Filament Health (FH.NEO) got the nod from the Financial Regulatory Authority to start trading on the OTC Pink Market in the United States under the symbol “FLHLF,” and has also submitted an application to get on the OTCQB Venture Market, according to a press release.
Actually, Filament isn’t stopping there. Their latest bid for greater exposure includes applications for the Depository Trust Company (DTC) to get eligibility to list there as well. Doing this simplifies the process of trading the company’s shares.
“We are pleased to have initiated our listing process on the OTCQB. This listing will enhance our visibility and allow Filament’s common shares to be more available to a broad range of institutional and retail investors in the United States,” said Benjamin Lightburn, CEO of Filament.
If you’re not familiar, Filament is a Vancouver-based natural psychedelics drug discovery and extraction tech company, engaged in natural extractions and commercialization, using its intellectual property portfolio, good manufacturing practices certified facility, and Health Canada dealer’s license for all natural psychedelics.
What are the OTC markets
The OTC Markets Group operates the OTCQX Best Market, the OTCQB Venture Market and the Pink Open Market, giving investors access to 11,000 United States and global securities. The OTC Link ATS, OTC Link ECN, offers connections to a network of broker-dealers providing liquidity and execution services.
The listing of the company’s shares on the OTCQB still needs to get the nod from the OTCQB board itself after satisfying the applicable listing requirements. The company will provide updates when they’re available.
Filament Health is down $0.055 and presently trading at $0.33.
—Joseph Morton
Full disclosure: Filament Health is an equity.guru marketing client.
